Efficacy of morantel sustained release trilaminate bolus against gastrointestinal nematodes in grazing dairy calves in Kenya

Summary The efficacy of morantel sustained release trilaminate (MSRT) bolus against gastrointestinal nematodes was evaluated under field conditions over a 10-month period. Twenty weaner calves were randomly divided into 2 groups of 10 calves each and grazed from March to December on adjacent, similarly contaminated paddocks. Group 1 calves (T-1) served as untreated controls while group 2 calves (T-2) were dosed at turnout with MSRT bolus designed to release morantel tartrate continuously for 90 days. The efficacy of MSRT was assessed by comparison of parasitological data (faecal worm egg counts, herbage larval counts, worm counts from tracer calves and set-stocked trial calves, determination of haematological parameters and pepsinogen levels), weight gains and clinical status of the animals. Faecal egg counts from the treated group (T-2) were reduced by 100% (P < 0·001) following treatment and remained significantly (P < 0·05) lower than counts from T-1 calves up to trial termination. The use of MSRT bolus resulted in a reduction of 92% (P < 0·001) in the number of gastrointestinal nematodes in set-stocked calves at the end of the study and a 55 to 85·7% reduction in herbage larval infectivity as reflected in lowered parasite burdens in tracer calves. At the trial termination, the control calves had gained on average (± s.d.) 59·4 ± 4·8 kg (200·0 ± 7·4 g day⁻¹) and the treated ones on an average 128·6 ± 10·5 kg (530·0 ± 13·1 g day⁻¹).

---

Eficacia De La Utilizacion De Bolos Trilaminados De Morantel Frente A Nematodos Gastrointestinales En Vacuno De Leche En Pastoreo En Kenya

Resumen Se evaluó la eficacia de los bolos trilaminados de liberación continua de morantel (MSRT) frente a nematodos gastrointestinales en condiciones de campo y durante un período de 10 meses. Un total de 20 terneros recién destetados fueron divididos al azar en dos grupos de 10 animales cada uno y mantenidos en pastoreo desde marzo hasta diciembre en parcelas adyacentes y con una carga parasitaria similar. Los terneros del grupo 1 (T-1) fueron los animales control y no recibieron ningun tratamiento, mientras que los terneros del grupo 2 (T-2) fueron tratados con MSRT al inicio del período de pastoreo; los MSRT estaban dise?ados para liberar tartrato de morantel de forma contínua durante 90 días. La eficacia de los MSRT se evaluó comparando datos parasitológicos (huevos en heces, larvas en el pasto, parásitos en los animales, parámetros hematológicos y niveles de pepsinógeno), ganancias de peso y datos clínicos. El número de huevos en heces en los animales T-2 se redujo en un 100% (P < 0·001) después del tratamiento y se mantuvo significativamente más bajo (P 0·05) que el de los animales T-1 durante todo el experimento. La utilización de MSRT resultó en una reducción del 92% (P < 0·001) en el número de nematodos gastrointestinales y en una reducción del 55 al 85·7% en el número de larvas en el pasto. La ganancia de peso final fue de 59·4 ± 4·8 kg en los animales T-1 (200·0 ± 7·4 g/día) y de 128·6 ± 10·5 kg en los animales T-2 (530·0 ± 13·1 g/día).

---

Efficacite Du Morantel Por Voie Orale Contre Des Nematodes Gastro-Intestinaux Chez Des Veaux Laitiers Au Kenya

Résumé L’efficacité du Morantel distribué par voie orale, contre des nématodes intestinaux fut évaluéein situ sur plus de 10 mois. 20 veaux sevrés furent répartis au hasard dans 2 groupes de 10 veaux chacuns et broutèrent de Mars à Décembre sur 2 parcelles adjacentes et contaminées de fa?on identique. Le premier groupe (T-1) servit de temoin alors que le deuxième groupe (T-2) re?ut du morantel de fa?on continue pendant 90 jours. L’efficacité du Morantel fut analysée par comparaison des données parasitologiques (nombre d’oeufs de nématode dans les faèces, nombre de larve dans l’herbe, nombre de nematodes chez des veaux de contr?le mobiles et non mobiles, determination des paramètres hématologiques et des tereurs en pepsinogène), des gains de poids et des caractéristiques cliniques des animaux. Le nombre d’oeufs dans les faeces furent réduits de 100% dans le groupe (T-2) (P < 0,001) après le traitement et perdura de fa?on significative (P < 0,05) en dessous des valeurs pour les veaux du groupe (T-1) et cela jusqu’à la fin de l’éxpérience. L’utilisation du Morantel par voie orale entra?na une réduction de 92% dans le nombre des nématodes intestinaux dans les veaux immobilisés à la fin de l’experimentation ainsi qu’une réduction de 55 à 85,7% des larves dans les herbages témoin d’une diminution des parasites rejetés par les animaux sentinels. A la fin de l’expérimentation, les veaux du groupe de contr?le gagnèrent en moyenne 59,4 kg ± 4,8 kg (200,0 ± 7,4 g/jour) alors que les animaux traités gagnèrent en moyenne 128,6 ± 10,5 kg (530,0 ± 13,1 g/jour).

     

Efficacy of the morantel sustained release trilaminate bolus against gastrointestinal nematodes and its influence on immunity in calves.

An experiment was conducted in calves to investigate the efficacy of a morantel sustained release trilaminate bolus (MSRT) to control gastrointestinal parasitism and to assess the development of immunity during the use of MSRT. Two groups (M and U) of four calves each were infected three times a week with a mixed Ostertagia ostertagi and Cooperia oncophora infection for 12 weeks. Calves of Group M received an MSRT at the start of the experiment. Twenty weeks after the start of the experiment, all animals, including a previously uninfected control group (C), received a challenge with 100,000 Ostertagia and 100,000 Cooperia. After a further 4 weeks all calves were necropsied for worm counts. During the trial calves were weighed and faecal egg counts, larval differentiation and pepsinogen concentrations were determined. The results demonstrated the high level of efficacy of the MSRT in reducing the faecal egg output and preventing parasitic gastroenteritis under conditions of a continuous high rate of infection. Efficacy of treatment was higher for Cooperia than for Ostertagia. Post-mortem worm counts suggested a partially impaired immunity build-up in Group M, at least for Cooperia.     

Efficacy of morantel sustained release bolus against gastrointestinal nematodes in first season grazing Holstein calves

The efficacy of the morantel sustained release bolus (MSRB) in reducing gastrointestinal parasitism in first season grazing calves was evaluated during the summer--autumn grazing seasons of 1982 and 1983 in western Oregon. Each of 38 calves (1982) and 40 calves (1983) were randomly assigned to either control or treatment groups which were given MSRB on the day of turnout onto pasture. Mean worm burdens from tracer calves grazed with treated animals in 1982 and 1983 showed overall reductions of 86.4% (P greater than 0.05) and 84.3% (P less than 0.01), respectively, compared to tracers grazed with controls. Ostertagia ostertagi, Cooperia oncophora and Nematodirus helvetianus were the primary nematodes collected at necropsy. Twelve full-season 1982 tracer animals (6 treated and 6 control) indicated an 88.1% (P less than 0.05) overall reduction in mean worm burdens. Mean fecal worm egg per gram (EPG) counts of treated animals reflected a reduction of 69% (P less than 0.05) in 1982 and 90% (P less than 0.05) in 1983. Autumn inhibition of O. ostertagi was observed. In the 1982 trial the control animals showed a slight mean weight gain advantage over the treated group from Day 84 until Day 160 (trial termination) when the mean difference was 7.9 kg. The final mean weight gain advantage of treated animals in 1983 was 13.5 kg (P less than 0.05). These trials demonstrated that the MSRB was an effective anthelmintic for reducing gastrointestinal parasitism in grazing calves and for decreasing pasture larval contamination.     

Field efficacy of a morantel sustained release bolus for control of gastrointestinal nematodes in yearling steers

The efficacy of a morantel sustained release bolus (MSRB) for control of gastrointestinal nematodes in yearling steers was evaluated over a 6-month grazing period commencing on 26 March 1982. Three groups of 15 steers were allotted to the following treatments: Group 1 -- one MSRB at start of trial; Group 2 -- one therapeutic dose of thiabendazole at start of trial; Group 3 -- untreated control. The treatment groups were grazed separately. Parasite egg counts (EPG), herbage larval counts, pepsinogen levels and weight gains were monitored. Every other month, sets of 2 parasite-free tracer calves were placed in the pasture grazed by each treatment group and allowed to graze for 3 weeks before being subsequently necropsied for worm counts. At the end of the trial, 6 animals from each group were also necropsied for worm counts. The MSRB treatment resulted in significantly lower egg counts, fewer infective larvae on pasture, lower pepsinogen levels and lower worm burdens in tracer calves than was the case for the untreated group, but generally the levels were not significantly different from those associated with the thiabendazole treatment. The mean weight gain for the MSRB treated steers showed a significant advantage (70.9 lb) over the untreated animals, but was not significantly different from those which received thiabendazole. Total worm counts at the end of the trial were not different from any treatment group.     

Evaluation of the morantel sustained release bolus in cows and calves

The efficacy of the morantel sustained release bolus (MSRB) in controlling gastrointestinal parasitism in beef cattle was assessed during the 1982 spring-autumn grazing season. Forty-eight cows and their calves were allotted to three equal groups. One group (T-1) served as a nonmedicated control group. One MSRB was administered to each calf of the T-2 group, and to each cow and calf of the T-3 group at the beginning of the study. The efficacy of the bolus was assessed by comparison of weight gain performance and parasitological data (fecal worm egg counts, herbage larval counts, worm counts from tracer and principal trial calves, and plasma pepsinogen level determinations). Though not statistically significant, treated calves from Group T-2 had a numerical mean weight gain advantage of 2.6 kg, and those from Group T-3 of 4.7 kg, over control calves. Average daily gains (ADG) for the three groups of calves were 0.69, 0.72, and 0.73 kg, respectively. Untreated cows from Group T-2 and treated cows from Group T-3 outperformed the control cows by 12.3 and 7.5 kg, respectively. Fecal worm egg counts from both groups of treated calves were significantly (P less than 0.01) lower than counts from control calves during the entire 169-day trial; notably, egg counts were reduced by 99% 28 days after MSRB administration to both groups of calves. There were no significant differences in the number of eggs counted from the three groups of cows, probably because of the very low numbers of eggs encountered. Mean total worm burdens of principal calves (six per group) necropsied at trial termination indicated a 91% (P less than 0.01) reduction in Group T-2 and an 87% reduction (P less than 0.01) in Group T-3. Worm-free tracer calves were introduced onto pastures every 28 days to monitor availability of infective larvae. The mean number of worms recovered at necropsy from tracer calves that grazed with control cattle increased as the season progressed. However, the numbers of parasites recovered each month from mid-August through mid-October from tracers that grazed pastures with treated cattle were lower (P less than 0.05) than those levels displayed at trial initiation. In addition, the mean numbers of worms from treated group tracers were lower than from the controls for each necropsy period.(ABSTRACT TRUNCATED AT 400 WORDS)     

Efficacy of morantel sustained-release bolus in control of gastrointestinal nematodes of weaned calves during the autumn-winter grazing season

A 168-day study was conducted to evaluate the efficacy of morantel tartrate sustained-release bolus (MSRB) in controlling gastrointestinal parasitism in weaned calves during autumn-winter grazing in the temperature climate of southern United States. Sixty-two weanling Angus heifers were used to assess treatment differences. Six sentinel heifers were necropsied to assess pretrial gastrointestinal worm counts. The remaining 56 heifers were assigned to 4 groups of 14 heifers each and were placed on four 4.86-hectare dormant Bermuda grass pastures (1 group/pasture) that had been no-till interseeded with cereal rye in early October. Heifers in 2 groups were given 1 MSRB in early November; the other 2 groups served as nonmedicated controls. Three heifers (principals) from each of the 4 groups were necropsied on posttreatment days 57, 112, and 168 (end of study) for total worm recovery. Eight 5-month-old tracer steers, raised worm-free from birth, grazed the 4 pastures (2/pastures) for the first 21 days of the study and then were kept in drylot for 21 days before being necropsied. Level of larval contamination of pastures grazed by control and MSRB-treated heifers were comparable, because the mean number of nematodes recovered from tracer steers grazing the control and MSRB pastures were 47,449 and 53,835, respectively. At 28 days after treatment, MSRB-treated heifers had lower (P less than 0.05) mean egg counts/g of feces than did control heifers (280 vs 13).(ABSTRACT TRUNCATED AT 250 WORDS)     

Evaluation of the morantel sustained release trilaminate in the control of parasitic gastroenteritis in first season grazing cattle

A novel intraruminal bolus developed for the sustained delivery of the anthelmintic morantel tartrate was evaluated in the seasonal control of parasitic gastroenteritis in first season grazing calves. The morantel sustained release trilaminate is a trilaminate sheet consisting of a central lamina of a morantel tartrate/ethylene vinyl acetate matrix coated on both sides with a thin impermeable layer of ethylene vinyl acetate. A symmetrical pattern of circular perforations punched through the device controls the release of morantel. Administration of the trilaminate to calves significantly reduced their faecal egg output compared with untreated controls and thus reduced pasture larval contamination. Clinical parasitic gastroenteritis was prevented in the treated calves and there were significant reductions in their worm burdens compared with the untreated control calves both during and at the end of the grazing season. The control of parasitic gastroenteritis resulted in a significantly greater (P less than 0.0001) weight gain, of 45 kg, by the treated calves.     

Efficacy of repeated doses of levamisole, morantel, fenbendazole, and ivermectin against gastrointestinal nematodes in ewes

Levamisole, morantel, fenbendazole, or ivermectin was administered at 2-week intervals from May 1 through Sept 14, 1985, to breeding ewes (20 ewes/drug) infected with various gastrointestinal nematodes. All ewes had fewer gastrointestinal nematode eggs per gram of feces (epg) after 2 treatments, compared with pretreatment epg counts. Ewes administered ivermectin continued to have a low mean epg (0 to 3) throughout the study. The mean epg counts of ewes treated with levamisole increased from 3 to 483 during the study. This increase was similar to that of ewes treated with morantel (7 to 485 epg). The mean epg count of fenbendazole-treated ewes increased from 4 to 192 during the study. By the end of the study, the mean epg counts when expressed as a percentage of the pretreatment epg counts were 4% (ivermectin), 249% (fenbendazole), 627% (levamisole), and 630% (morantel). With the exception of the ivermectin-treated ewes, the epg count increased almost linearly in the ewes after the 2nd anthelmintic treatment. These data indicate that the gastrointestinal nematodes (including Haemonchus contortus) may have developed more resistance to levamisole and morantel than to fenbendazole. On the basis of the epg counts, resistance to ivermectin did not develop during the 4.5-month treatment period. The percentage of ewes shedding eggs after 2, 4, and 6 anthelmintic treatments was lowest for ewes treated with ivermectin (20%) and was similar (40%) for ewes treated with 1 of the other 3 anthelmintics. At the conclusion of the study, most of the ewes (90%) were shedding at least a small number of eggs, regardless of the anthelmintic treatment.(ABSTRACT TRUNCATED AT 250 WORDS)     

Grazing study in Ireland using the morantel sustained release bolus for controlling nematodiasis in calves

The morantel sustained release bolus was administered at turnout to first-season grazing calves in order to assess its efficacy in the seasonal control of infection by nematode parasites in Ireland. The pastures grazed by control calves showed a marked increase in gastrointestinal trichostrongylid infective larvae by September, while numbers of infective larvae on pasture grazed by bolus-treated calves remained at a low level throughout the grazing season. In consequence, the controls showed significantly higher worm egg counts in late season and significantly higher worm burdens (mainly Ostertagia spp) at necropsy carried out in November on representative number of principal animals selected from each group. These reduced worm burdens were attributed to the suppression of egg output during the early part of the season as a result of treatment with the morantel sustained release bolus at turnout in the spring. Pasture contamination with Dictyocaulus viviparus larvae was present on all treatment pastures. The bolus-treated calves however were subjected to an increase in D. viviparus infection which occurred on their pasture in late season after the active life of the bolus had expired. It was concluded that bolus treatment delayed (rather than prevented) the buildup of D. viviparus infection on the pasture by 60-90 days.     

The effectiveness of the new morantel sustained-release trilaminate bolus against gastrointestinal nematode infections in cattle in their first grazing period

The efficacy of a recently developed Morantel-Sustained-Release-Trilaminate-Bolus (Paratect Flex Bolus [PFB]-Pfizer Inc.) against gastrointestinal nematode infections in cattle was assessed by monitoring faecal egg counts (EpG), herbage larval counts, serum pepsinogen levels and liveweight gains in first season calves. In two field trials (1987 and 1988), a PFB-Bolus was administered to two different groups of animals (1987: 15 calves; 1988:13 calves) at turnout (29 May 1987; 26 May 1988), control groups were included. In 1988, 13 calves received for comparison an Oxfendazole-Release-Bolus (Systamex Intervall Bolus [OXF]-Coopers Inc.). All groups were grazed on adjacent but separately fenced pastures throughout the season, until housing (27 October 1987; 15 October 1988). When compared with controls, the PFB-groups showed significantly lower EpG values and consequently, lower herbage larval counts throughout the season in both trials. From day 30 after turnout, the PFB-group had significantly lower serum pepsinogen levels, which reflects the low degree of abomasal damage in these animals. When compared to controls, the PFB-treated animals showed significantly higher weight performances. The mean weight-gain benefit of PFB-treated animals was +12.5 kg (p less than 0.05) and +21.1 kg (p less than 0.005) in 1987 and 1988, resp. No difference occurred between PFB-treated and OXF-treated calves, the latter outperformed the control animals by +21.6 kg (p less than 0.005).     

Efficacy of morantel against nematode populations in calves exposed on a pasture stocked for two years with morantel sustained-release bolus-treated calves

Two groups of 10 parasite-free calves were maintained either for 2 weeks on a pasture grazed by nonmedicated cattle (pasture A) or for 3 weeks on a pasture grazed by morantel sustained-release bolus-treated cattle (pasture B) for the preceding 2 years. After a 4-week holding period to allow for maturation of acquired gastrointestinal nematodes, 5 calves from each group were administered a therapeutic dose (10 mg/kg of body weight) of morantel tartrate. All calves were necropsied 1 week later, and the abomasal and small intestinal nematodes were isolated, identified, and enumerated. A comparison of efficacies between nonmedicated and morantel tartrate-treated calves of each pasture demonstrated that morantel was equally effective against the gastrointestinal nematode infections, regardless of infection source (ie, pasture A vs pasture B). The overall nematode reductions due to morantel tartrate treatment of calves that grazed pastures A and B were 98% and 96%, respectively. It was concluded that the sensitivity of gastrointestinal nematodes to morantel tartrate was not diminished in calves maintained on pasture B, which had been stocked with morantel sustained-release bolus-treated calves for the preceding 2 grazing seasons.     

Efficacy of a morantel sustained-release bolus for the control of gastrointestinal nematodes in Florida dairy heifers

The effectiveness of a morantel sustained-release bolus (MSRB) in controlling gastrointestinal nematode infections was determined in 70 Holstein heifer calves with no prior grazing experience. Calves were allotted to 2 treatment groups and were maintained in Florida during the grazing season on divided pastures of equal area. One MSRB was administered to each calf in 1 group at the time of turnout onto spring pasture, whereas calves in the other group remained as nonmedicated controls. By the end of the grazing season, treatment resulted in significantly (P less than 0.05) lower worm burdens and significantly improved weight gains. The MSRB-treated calves were able to reach breeding weight 2 to 4 weeks earlier than did nonmedicated calves.     

Efficacy of ivermectin against gastrointestinal nematodes in dromedary camels

The anthelmintic activity of ivermectin when administered orally and subcutaneously at a dosage of 0.2 mg/kg of body weight was evaluated in 4 trials involving 20 dromedary camels (Camelus dromedarius). Fecal egg counts were made on the day of treatment and at 2, 4, and 10 weeks after treatment. Trichostrongylid egg counts were reduced by a maximum of 100% when ivermectin was administered orally and by greater than 88% when given subcutaneously. Egg counts of Trichuris spp were reduced by greater than 85% with oral administration, but increased following subcutaneous treatment. No adverse local or systemic reactions were observed following treatment with ivermectin by either route.     

A morantel sustained-release bolus for the control of gastro-intestinal nematodes in grazing calves

Prophylactic (summer) and/or therapeutic (autumn) administrations of an intra-ruminal sustained-release bolus (MSRB) containing morantel tartrate were compared for the control of gastro-intestinal nematodes in grazing dairy calves over an 8-month period (December to August). The MSRB was designed to release morantel tartrate at 150 mg/day for 90 days.

Treated and untreated groups of calves grazed separate replicated pastures. Both groups of calves receiving the MSRB at the beginning of summer showed a significant mean liveweight advantage (17.7 kg and 20.7 kg for the summer and summer/autumn treated groups, respectively) at the end of the trial period, when compared with untreated calves. The liveweight advantage of calves receiving the MSRB in autumn only (6.5 kg) was not significantly different from that of the controls.

Both the summer and autumn administrations of the MSRB prevented the accumulation of Pre-Type II burdens of Ostertagia spp.

Retention rates of the MSRB were high and chemical analysis of faecal samples indicated a fairly constant release of the anthelmintic over the predicted 90-day period.

The results indicate that the MSRB is potentially useful for the control of gastro-intestinal nematodes, and particularly for the production of ’safe’ pasture. The MSRB could provide an effective alternative to integrated control based primarily on grazing management.     

Feed intake of grazing calves exposed to trichostrongyle infection and treated with the morantel sustained release bolus

Herbage intake was measured in two groups of 20 first-year grazing cattle. The animals in one group each received a morantel sustained release bolus at turnout to control nematode parasitism and the animals in the other group remained untreated. The latter group showed a mean peak faecal egg count of 655 eggs per gram (e.p.g.) in October associated with high serum pepsinogen concentration and clinical signs of ostertagiasis, compared with a peak of 119 e.p.g. in the treated group which remained in good health. In September the daily voluntary feed intake of the untreated animals was significantly depressed (94 g kg-1 body weight vs. 77 g kg-1 P less than 0.001), but no difference in digestive efficiency was recorded between the two groups. This difference in feed intake was associated with a 47 kg mean live weight advantage of the treated animals at housing.